logo
  Join        Login             Stock Quote

Repligen Corporation Acts to Prevent Proxy Proposal That Would Benefit Shareholders

Wednesday, April 11, 2012 12:18 PM


CHICAGO, April 11, 2012 /PRNewswire/ -- Ronald L. Chez, a private investor who owns 9.2% of Repligen, submitted a proxy proposal to reduce the threshold of shareholder approval necessary to call a special meeting from the holders of a majority of Repligen (Nasdaq: RGEN) stock to 20%.  On April 4, 2012 Repligen filed a rejection request with the Securities and Exchange Commission (SEC) regarding the proposal.  "My proposal warrants a vote by all shareholders rather than what I believe to be a convoluted and dismissive response by a board that owns only 5.8% of the company," said Mr. Chez.

Mr. Chez has responded to the SEC with regard to repeated actions of Repligen attempting to deny his shareholder friendly proposal for inclusion in Repligen's 2012 proxy statement.  The matter is currently under review by the SEC.

"In previous meetings, correspondence and telephone calls, Repligen's Board consistently expressed their appreciative and positive response to my suggestions, and their desire to work with me in a cooperative manner to enhance shareholder value,"  stated Mr. Chez. However, "since my March 5, 2012 letter to the co-Chairperson of Repligen's board (available for review in my Schedule 13-D also filed on that date), the directors have refused to communicate with me despite my numerous attempts to do so."

Mr. Chez added, "Repligen's management has recently made several decisions that have the potential to deliver positive operating results after 10 years of lackluster performance and resultant shareholder frustration.  Until very recently, Repligen's stock price was essentially flat with its price a decade ago.  I believe the management, with constructive involvement by a Board with strong operating and entrepreneurial experience, has significant opportunities to build a strong, sustainably profitable company."

"It would appear that the directors of Repligen are resistant to a fresh perspective.  The directors wish to perpetuate their position when, with the exception only of Dr. Herlihy and one other director, they have almost 'no skin in the game'.  If the current directors (who own only 3.5% of the company excluding Dr. Herlihy's shares) are the right stewards for Repligen, there is no reason, other than further efforts to entrench themselves, to try to obviate this proposal.  It would appear that the directors are resistant to a fresh perspective that could benefit Repligen and its shareholders."

"Repligen's shareholders should communicate their support of inclusion of this proxy proposal to the Company's Board of Directors so that the proposal can be voted on by all shareholders. The shareholders, the owners of the company, rather than an insulated board, should have the right to decide whether this proposal will help Repligen achieve its goals of benefiting patients, and ultimately shareholders."

 


 

SOURCE Ronald L. Chez

(Source: PR Newswire )
(Source: Quotemedia)

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.